Perspective Therapeutics (CATX)

• Market cap: $209M
• 1 day: -2.43%
• 5 days: 1.44%
• 1 month: 28.31%
• 3 months: -16.12%
• 6 months: -18.31%
• Year to date: -15.11%
• 1 year: -8.17%
• 5 years: -37.56%
• 10 years: -71.67%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140